Trial NCT05564338

View at ClinicalTrials.gov 
Org. Study IDs: BGB-A317-Sitravatinib-303

Last trial update was posted on 2023-06-07

MeSH Interventions

Tislelizumab

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

Study has voluntarily discontinued due to a change in the company-level development strategy and is not because of any safety concern or the request from any health authority worldwide.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID